(Q50674112)

17 March 2018

title

Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy. (English)

1 reference

17 March 2018

1 reference

3

Noriko Inada

1 reference

17 March 2018

author name string

Makiko Katagiri

1

1 reference

17 March 2018

Jun Shoji

2

1 reference

17 March 2018

Satoshi Kato

4

1 reference

17 March 2018

Shigehiko Kitano

5

1 reference

17 March 2018

Yasuko Uchigata

6

1 reference

17 March 2018

publication date

15 March 2017

1 reference

17 March 2018

International Ophthalmology

published in

1 reference

17 March 2018

https://scigraph.springernature.com/pub.10.1007/s10792-017-0499-1

exact match

0 references

cites work

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Vitreous leptin levels in retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

The RAGE axis in early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

TAGE (toxic AGEs) theory in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Upregulation of RAGE and its ligands in proliferative retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

DNA Aptamer Raised against Advanced Glycation End Products Prevents Abnormalities in Electroretinograms of Experimental Diabetic Retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Biological action of leptin as an angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10792-017-0499-1

Elevation of vitreous leptin in diabetic retinopathy and retinal detachment

21 January 2018

1 reference

12 December 2020

Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy

1 reference

12 December 2020

Increased expression of placenta growth factor in proliferative diabetic retinopathy.

1 reference

12 December 2020

Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells

1 reference

12 December 2020

Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

1 reference

12 December 2020

10.1007/S10792-017-0499-1

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

28299499

1 reference

17 March 2018